Philipp Kiewe

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

Uwe Platzbecker, Ulrich Germing, Katharina S. Götze et al. · The Lancet Oncology · 2017 · 286 citations

Dose-finding Study, Hematological Malignancy, Hematology +6

Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer

Philipp Kiewe, Stephan Hasmüller, Steffen Kahlert et al. · Clinical Cancer Research · 2006 · 194 citations · Full text

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma

Agnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger et al. · Journal of Clinical Oncology · 2016 · 131 citations

CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients

Lars Fischer, Agnieszka Korfel, Sebastian Pfeiffer et al. · Clinical Cancer Research · 2009 · 113 citations

Neuro-oncology, Lymphoid Neoplasia, Medicine +15

Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial

Patrick Roth, Peter Martus, Philipp Kiewe et al. · Neurology · 2012 · 86 citations